Related Experiment Videos
Tacrolimus effect on rosacea
Joel T M Bamford1, Barbara A Elliott, Irina V Haller
1Dermatology Section, St. Mary's/Duluth Clinic Health System, MN 55805, USA. jbamford@smdc.org
Journal of the American Academy of Dermatology
|December 31, 2003
Abstract:
Twenty-four patients with erythrotelangiectatic or papulopustular rosacea were treated with 0.1% tacrolimus topical ointment in a 12-week open-label trial. Erythema was significantly improved in both rosacea subtypes (P<.05). There was no decrease in the number of papulopustular lesions. Side effects were consistent with those on the tacrolimus topical ointment labeling.